Novavax acquires Fielding for $31.5 million

NOX will acquire all the outstanding stock of Fielding Pharmaceutical (St. Louis, Mo.) for $31.5 million, consisting of $13 million in cash and $18.5 million in NOX stock. NOX may pay an additional $5...